Susan Hasty, Publisher
Table of Contents . . . April 19th, 1999Non-Subscriber - Summaries Only
Therapy (HCV) - Review of IFN Studies Provides Interesting New Data
Acute Hepatitis - New Lateral Sclerosis Drug Causes Liver Problems
Complicating Conditions - 10 Percent of Patients with HCV-Renal Disease Require Dialysis
Immunology - Ribavirin Promotes Type-1 Cytokine-Mediated Response
Pathogenesis (HGV) - New Study Finds GBV-C/HGV Not Hepatitis at All
Virology (HCV) - Genotype Changes Common in Hemophiliacs
Conference Coverage - Hepatitis E Vaccine Safe, Immunogenic in Phase I Test
Therapy - Treatments Studied for Hepatitis B and C
Vaccine Development - Data Supporting Malaria and Hepatitis Vaccine Development Reported
Risk Factors (Liver Cancer) - "Risk Factors in Development of Liver Cancer: Comparative Analysis of Hepatitis B Virus Carriers and Noncarriers."
Pathogenesis (HCV) - "Hepatitis C Virus Core Protein and Host Defense."
Pathogenesis (HCV) - "Liver-Derived Host Factors In Hepatitis C Translation."
Risk Factors (HCC) - "Plasma Folate, Chronic HBV Infection and Primary Liver Cancer."
Hepatocellular Carcinoma - "Hepatitis B Virus x Protein Inhibits Nucleotide Excision Repair."